Franck Fieschi Selected Research

Franck Fieschi Research Topics

Disease

28	Infections 09/2023 - 11/2002
10	Neoplasms (Cancer) 01/2023 - 09/2011
5	Melanoma (Melanoma, Malignant) 11/2023 - 01/2019
5	Virus Diseases (Viral Diseases) 01/2016 - 07/2003
5	HIV Infections (HIV Infection) 03/2015 - 03/2010
4	Inflammation (Inflammations) 11/2023 - 11/2011
3	Chronic Granulomatous Disease 01/2023 - 10/2010
3	Communicable Diseases (Infectious Diseases) 11/2011 - 05/2006
2	COVID-19 09/2023 - 11/2021
2	Atherosclerosis 06/2021 - 11/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2021 - 09/2011
2	Autoimmune Diseases (Autoimmune Disease) 10/2020 - 10/2020
1	Bacterial Infections (Bacterial Infection) 02/2024
1	Endotoxemia 11/2023
1	Immune System Diseases (Immune Disorders) 01/2023
1	Carcinogenesis 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2021
1	Lupus Nephritis 11/2021
1	Hypertension (High Blood Pressure) 06/2021
1	Fibrosis (Cirrhosis) 06/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 06/2021
1	Schistosomiasis (Bilharziasis) 10/2020
1	Hypersensitivity (Allergy) 10/2020
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2017
1	Dengue (Dengue Fever) 04/2014
1	Pathologic Processes 11/2011
1	Arthritis (Polyarthritis) 09/2011

Drug/Important Bio-Agent (IBA)

26	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 02/2024 - 11/2002
16	C-Type Lectins (C-Type Lectin)IBA 11/2023 - 05/2006
13	LigandsIBA 04/2023 - 05/2007
8	Polysaccharides (Glycans)IBA 11/2023 - 11/2011
7	Glycoproteins (Glycoprotein)IBA 11/2023 - 01/2019
6	Proteins (Proteins, Gene)FDA Link 09/2023 - 11/2011
5	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2023 - 04/2005
4	Superoxides (Superoxide)IBA 11/2023 - 04/2005
4	LectinsIBA 01/2023 - 05/2007
4	Antiviral Agents (Antivirals)IBA 11/2016 - 07/2007
3	AntigensIBA 11/2022 - 01/2019
3	CarbohydratesIBA 10/2020 - 07/2007
3	AnionsIBA 01/2019 - 04/2005
3	IntegrinsIBA 03/2010 - 07/2003
2	FucoseIBA 11/2023 - 11/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023 - 01/2019
2	LipidsIBA 09/2023 - 11/2021
2	GlycoconjugatesIBA 10/2021 - 05/2007
2	cytochrome b558IBA 12/2017 - 12/2014
2	Dendrimers (Dendrons)IBA 02/2013 - 07/2011
2	dendronIBA 01/2012 - 03/2010
2	AntibodiesIBA 07/2003 - 11/2002
1	Peroxynitrous Acid (Peroxynitrite)IBA 11/2023
1	CytokinesIBA 01/2023
1	EpitopesIBA 11/2022
1	Viral AntigensIBA 11/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2022
1	Anti-Infective Agents (Microbicides)IBA 10/2022
1	Tn antigenIBA 01/2022
1	AcetylgalactosamineIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Threonine (L-Threonine)FDA Link 01/2022
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 01/2022
1	HDL LipoproteinsIBA 11/2021
1	CholesterolIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	calix(4)areneIBA 10/2021
1	Calixarenes (Calixarene)IBA 10/2021
1	AcidsIBA 10/2021
1	Hydroxamic Acids (Hydroxamic Acid)IBA 10/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2021
1	MucinsIBA 10/2020
1	VaccinesIBA 10/2020
1	Carrier Proteins (Binding Protein)IBA 10/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Toll-Like Receptor 7IBA 01/2019
1	MannosidesIBA 01/2019
1	Conjugate VaccinesIBA 01/2019
1	Phosphotransferases (Kinase)IBA 12/2017
1	phorbolIBA 12/2017
1	Cell Adhesion MoleculesIBA 01/2012
1	ChemokinesIBA 01/2012
1	ClusterinIBA 11/2011
1	celastrolIBA 09/2011
1	PolyestersIBA 07/2011
1	Intercellular Adhesion Molecule-3IBA 03/2010
1	DisaccharidesIBA 07/2007

Therapy/Procedure

2	Therapeutics 02/2024 - 10/2020